Al-Omar Nuha A, Al-Qutub Montaser N, Ramalingam Sundar, Al-Kindi Mohammad, Nooh Nasser, Ar-Regaie Aws, Wang Hom-Lay, Al-Hezaimi Khalid
Int J Periodontics Restorative Dent. 2016;36 Suppl:s161-70. doi: 10.11607/prd.2375.
The aim of this in vivo microcomputed tomographic (μCT) experiment was to assess in real time the efficacy of a combination of recombinant human bone morphogenetic protein-2 (rhBMP-2) and biphasic calcium phosphate (BCP), with and without resorbable collagen membrane (CM), in regeneration of standardized calvarial defects (SCDs) in rats. A total of 30 female Wistar albino rats (n = 10/group) with a mean age and weight of 7.5 months and 275 g, respectively, were used. With the rats under general anesthesia, the calvaria were exposed using full-thickness periosteal flaps and unilateral SCDs of 4.6 mm diameter were created on the left parietal bone. Defects were left untreated (control group) or randomly filled with either BCP soaked in rhBMP-2 and then covered with CM (BMP + BCP + CM group) or BCP soaked in rhBMP-2 alone (BMP + BCP group). In vivo μCT scans were done at baseline and 2, 4, 6, and 8 weeks. Newly formed bone (NFB) and remaining BCP particles were assessed for their volumes (NFBV, BCPV, respectively) and mineral densities (NFBMD, BCPMD, respectively). In vivo μCT results showed scanty amounts of new bone at the peripheries of the defect in the control group. In the other two groups, near complete defect closure was evident at 8 weeks. The mean NFBV after 8 weeks was 4.63 ± 0.96 mm(3), 11.82 ± 1.17 mm(3), and 13.85 ± 1.89 mm(3) for the control, BMP + BCP + CM, and BMP + BCP groups, respectively. After 8 weeks, the mean NFBMD was 0.38 ± 0.03 g/mm(3), 0.24 ± 0.07 g/mm(3), and 0.35 ± 0.03 g/mm(3) for the control, BMP + BCP + CM, and BMP + BCP groups, respectively. After 8 weeks, the mean BCPV and BCPMD values for the BMP + BCP + CM and BMP + BCP groups were 2.73 ± 0.65 mm(3), 0.33 ± 0.08 g/mm(3), 2.49 ± 0.71 mm(3), and 0.28 ± 0.03 g/mm(3), respectively. The present real-time in vivo μCT experiment demonstrated that BMP + BCP, either with or without CM, was effective in promoting bone regeneration within rat SCDs and enabled new bone formation starting as early as 2 weeks.
本体内微型计算机断层扫描(μCT)实验的目的是实时评估重组人骨形态发生蛋白-2(rhBMP-2)与双相磷酸钙(BCP)联合使用,以及使用和不使用可吸收胶原膜(CM)时,对大鼠标准化颅骨缺损(SCD)再生的效果。总共使用了30只雌性Wistar白化大鼠(每组10只),平均年龄和体重分别为7.5个月和275克。在大鼠全身麻醉下,通过全层骨膜瓣暴露颅骨,并在左顶骨上制作直径4.6毫米的单侧SCD。缺损不进行处理(对照组),或者随机填充浸泡过rhBMP-2的BCP,然后覆盖CM(BMP + BCP + CM组),或者仅填充浸泡过rhBMP-2的BCP(BMP + BCP组)。在基线以及第2、4、6和8周进行体内μCT扫描。评估新形成骨(NFB)和剩余BCP颗粒的体积(分别为NFBV、BCPV)和矿物质密度(分别为NFBMD、BCPMD)。体内μCT结果显示,对照组缺损周边新骨量很少。在其他两组中,8周时缺损几乎完全闭合。8周后,对照组、BMP + BCP + CM组和BMP + BCP组的平均NFBV分别为4.63±0.96立方毫米、11.82±1.17立方毫米和13.85±1.89立方毫米。8周后,对照组、BMP + BCP + CM组和BMP + BCP组的平均NFBMD分别为0.38±0.03克/立方毫米、0.24±0.07克/立方毫米和0.35±0.03克/立方毫米。8周后,BMP + BCP + CM组和BMP + BCP组的平均BCPV和BCPMD值分别为2.73±0.65立方毫米、0.33±0.08克/立方毫米、2.49±0.71立方毫米和0.28±0.03克/立方毫米。本次实时体内μCT实验表明,BMP + BCP无论是否使用CM,均能有效促进大鼠SCD内的骨再生,并能早在2周时就开始形成新骨。